New research has revealed the role of two membrane proteins in the spread of misfolded α-synuclein from neuron to neuron.

About 1 million Americans suffer from Parkinson's disease, with around 90,000 new cases diagnosed each year, according to the ...

More than a decade has passed since researchers led by Dennis Selkoe of Brigham and Women’s Hospital in Boston first reported that when α-synuclein has its druthers, it prefers the company of three ...

Alzheimer’s disease is a long, slow neurodegenerative calamity, and scientists are still hunting for blood biomarkers that reflect all its specific stages. At the Clinical Trials on Alzheimer’s ...

Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by the aggregation of alpha-synuclein in the brain. Now, scientists have developed a radioligand that facilitates the ...

Inspired by a creature from Greek mythology, researchers have created a ‘two-headed’ drug that prevents the production of the toxic protein linked to Parkinson’s disease before destroying the RNA ...

SynuSight Biotech has licensed (18) F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment ...

The so-called isolated REM-sleep behavior disorder is a condition that can provide an indication of Parkinson's disease well in advance. A research team headed by Professor Dr Erdem Gültekin Tamgüney ...

Case Western Reserve researchers have found a unique biochemical route that plays a role in Parkinson's disease.